"Research site"

During the past decade, Avant Research Associates LLC conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 16 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 14 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Avant Research Associates LLC" #1 sponsor was "Allergan" with 5 trials, followed by "Pfizer" with 5 trials sponsored, "Celgene" with 3 trials sponsored, "Allakos Inc." with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Avant Research Associates LLC" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Beaufort CRO" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Avant Research Associates LLC" are "Gastroparesis" (5 trials), "Diabetes Mellitus" (4 trials), "Acne Vulgaris" (3 trials), "Cardiovascular Disease" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Avant Research Associates LLC" in a lesser frequency.

Most popular intervention types in "Avant Research Associates LLC" are "Drug" (35 trials), "Other" (5 trials), "Device" (2 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Relamorelin" (4 trials), "Ozanimod" (3 trials), "AK002" (2 trials) and "Abrocitinib 200 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Avant Research Associates LLC" are 37 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Avant Research Associates LLC". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Avant Research Associates LLC, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Avant Research Associates LLC, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".